@article{oai:repo.qst.go.jp:00080890,
 author = {Zhao-Hui, Jin and B Tsuji, Atsushi and Mélissa, Degardin and Sugyo, Aya and Obara, Satoshi and Wakizaka, Hidekatsu and Nagatsu, Kotaro and Hu, Kuan and Ming-Rong, Zhang and Dumy, Pascal and Boturyn, Didier and Higashi, Tatsuya and Zhao-Hui, Jin and Atsushi, Tsuji and Aya, Sugyo and Satoshi, Obara and Hidekatsu, Wakizaka and Kotaro, Nagatsu and Kuan, Hu and Zhang, Ming-Rong and Tatsuya, Higashi},
 issue = {23},
 journal = {Clinical Cancer Research},
 month = {Sep},
 note = {Ovarian cancer peritoneal metastases (OCPMs) are a pathophysiologically heterogeneous group of tumors that are rarely curable. αvβ3 integrin (αvβ3) is overexpressed on tumoral neovessels and frequently on ovarian cancer cells. Here, using two clinically relevant αvβ3-positive OCPM mouse models, we studied the theranostic potential of an αvβ3-specific radiopeptide, 64Cu-cyclam-RAFT-c(-RGDfK-)4 (64Cu-RaftRGD), and its intra- and intertumoral distribution in relation to the tumor microenvironment.},
 pages = {6230--6241},
 title = {Radiotheranostic Agent 64Cu-cyclam-RAFT-c(-RGDfK-)4 for Management of Peritoneal Metastasis in Ovarian Cancer},
 volume = {26},
 year = {2020}
}